What's new

Human medicines European public assessment report (EPAR): Bomyntra, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR): Bomyntra, denosumab, Status: Opinion

May 23, 2025 - 13:35
 0
Human medicines European public assessment report (EPAR): Bomyntra, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Bomyntra, denosumab, Status: Opinion
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Blenrep, belantamab ma...

Next Article

Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib,...

Related Posts

Human medicines European public assessment report (EPAR): Ezmekly, mirdametinib, Status: Opinion

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Actelsar HCT, telmisartan,hydrochlorothiazide, Date of authorisation: 13/03/2013, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0